Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Chikungunya virus (CHIKV) seroprevalence in the local population of the Cook Islands and Vanuatu and associated environmental and social factors A first CHIKV seroprevalence study in two South Pacific communities

Charlotte E.B. Saretzki, Gerhard Dobler, Elisabeth Iro, Yin May, Douglas Tou, Eteta Lockington, Michael Ala, Nicole Heussen, Bruno S.J. Phiri, Thomas Küpper
doi: https://doi.org/10.1101/2022.07.07.22277208
Charlotte E.B. Saretzki
aInstitute for Occupational and Social Medicine, RWTH Aachen Technical University, Aachen/ Germany. Pauwelsstraße 30, 52074 Aachen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Charlotte.saretzki{at}rwth-aachen.de
Gerhard Dobler
bBundeswehr Institute of Microbiology, Munich/Germany. Neuherbergstraße 11, Ernst-von-Bergmann-Kaserne, 80937 München, Germany
Roles: Full Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisabeth Iro
cCook Islands Ministry of Health, Rarotonga/Cook Islands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin May
dCook Islands Ministry of Health, Rarotonga Hospital, Rarotonga/Cook Islands
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas Tou
eCook Islands Ministry of Health, Rarotonga Laboratory, Rarotonga/Cook Islands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eteta Lockington
fCook Islands Ministry of Health, Aitutaki Laboratory, Aitutaki/Cook Islands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Ala
gNorthern Provincial Hospital Laboratory, Espiritu Santo/Vanuatu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Heussen
hDepartment of Medical Statistics, RWTH Aachen Technical University, Aachen/Germany. Pauwelsstraße 19, 52074 Aachen, Germany
iCenter of Biostatistics and Epidemiology, Medical School, Sigmund Freud University, Vienna, Sigmund Freud Platz 3, 1020 Vienna, Austria
Roles: Full Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno S.J. Phiri
jCentral Veterinary Research Institute (CVRI), Ministry of Fisheries and Livestock, P.O. Box 33980, Lusaka, Zambia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Küpper
aInstitute for Occupational and Social Medicine, RWTH Aachen Technical University, Aachen/ Germany. Pauwelsstraße 30, 52074 Aachen, Germany
Roles: Full Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Arthropod-borne diseases pose a significant and increasing risk to global health. Given its rapid dissemination to all inhabited continents, initiating large-scale outbreaks with severe human infections and economic loss, the Chikungunya virus (CHIKV) is one of the most important arboviruses worldwide. Despite its significance, the real global impact of CHIKV remains underestimated as outbreak data are often incomplete and solely based on syndromic surveillance. During 2011-2016, the South Pacific Region was severely affected by several CHIKV-epidemics, still the area is underrepresented in arboviral research.

Methods 465 outpatient serum samples collected between 08/2016 and 04/2017 on three islands of the island states Vanuatu (Espiritu Santo) and the Cook Islands (Rarotonga, Aitutaki) were tested for anti-CHIKV specific antibodies using Enzyme-linked immunosorbent Assays.

Results A total of 30% (Cook Islands) and 8% (Vanuatu) of specimens were found positive for anti-CHIKV specific antibodies with major variations in national and intranational immunity levels. Seroprevalence throughout all age groups was relatively constant. Comparing the different study settings, four potential outbreak-protective factors were identified: presence of Ae. albopictus (in absence of ECSA E1-A226V-mutation CHIKV), as well as low levels of local population densities, residents’ travel activity and tourism.

Conclusion This is the first seroprevalence study focussing on an arboviral disease in the Cook Islands and Vanuatu. It highlights the impact of the 2014/2015 CHIKV epidemic on the Cook Islands population and shows that a notable part of the Vanuatu test population was exposed to CHIKV although no outbreaks were reported. Our findings supplement the knowledge concerning CHIKV epidemics in the South Pacific Region and contribute to a better understanding of virus dissemination, including outbreak modifying factors. They may support preventive and rapid response measures in affected areas, travel-related risk assessment and infection identification in returning travellers.

Author Summary Mosquito-borne viral infections pose an increasing risk to global health. As they mainly circulate in tropical regions comprised of low-resource countries and affect already vulnerable populations, these diseases have an immense impact on the socio-economic sector. Worldwide, the Chikungunya virus (CHIKV) represents one of the most important arboviruses. Yet, despite its significance, reliable data to understand many populations’ real disease burden is still missing. One example is the South Pacific Region (SPR), which has been severely affected by numerous CHIKV outbreaks since 2011. Epidemiological data is indispensable for the implementation of strategies for optimal allocation of limited resources, efficient early intervention, vector control as well as to understand the virus’ geographical distribution and its contribution to global morbidity. We therefore conducted a CHIKV seroprevalence study in the local populations of two Pacific Island states – the Cook Islands and Vanuatu. Our results show that during the 2014/2015 CHIKV epidemic on the Cook Islands about 30% of the local population has been affected. Although no outbreak was ever officially reported in Vanuatu, a notable part of the respective test population was proven to have been exposed to CHIKV as well. By comparing our two study settings we further identified several environmental and social factors with potential outbreak modifying effect.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was supported by: Aachen Dental and Medical Expeditions (ADEMED e.V. https://www.ademed.de/), a non-profit society to support research in travel medicine [grant number 180627] (Author: CS, funding: financial). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. and by the German Army Institute of Microbiology (Author: CS, funding: materials and use of their laboratory [no grant / grant number]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study was approved by the ethical committees of RWTH Aachen University (051/16_09/05/2016) and with the local authorities of the Cook Islands (Research permit reference number #16-16) and Vanuatu (Ref.: MOH/DG 10/1/1-GKT/lr).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • charlotte.saretzki{at}rwth-aachen.de; tkuepper{at}ukaachen.de

  • gerharddobler{at}bundeswehr.org

  • elizabeth.iro{at}cookislands.gov.ck

  • yin.may{at}cookislands.gov.ck

  • douglas.tou{at}cookislands.gov.ck

  • eteta.lockington{at}cookislands.gov.ck

  • alam{at}vanuatu.gov.vu

  • nheussen{at}ukaachen.de

  • nicole.heussen{at}med.sfu.ac.at

Data Availability

See file "supplemental data"

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 10, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Chikungunya virus (CHIKV) seroprevalence in the local population of the Cook Islands and Vanuatu and associated environmental and social factors A first CHIKV seroprevalence study in two South Pacific communities
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Chikungunya virus (CHIKV) seroprevalence in the local population of the Cook Islands and Vanuatu and associated environmental and social factors A first CHIKV seroprevalence study in two South Pacific communities
Charlotte E.B. Saretzki, Gerhard Dobler, Elisabeth Iro, Yin May, Douglas Tou, Eteta Lockington, Michael Ala, Nicole Heussen, Bruno S.J. Phiri, Thomas Küpper
medRxiv 2022.07.07.22277208; doi: https://doi.org/10.1101/2022.07.07.22277208
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Chikungunya virus (CHIKV) seroprevalence in the local population of the Cook Islands and Vanuatu and associated environmental and social factors A first CHIKV seroprevalence study in two South Pacific communities
Charlotte E.B. Saretzki, Gerhard Dobler, Elisabeth Iro, Yin May, Douglas Tou, Eteta Lockington, Michael Ala, Nicole Heussen, Bruno S.J. Phiri, Thomas Küpper
medRxiv 2022.07.07.22277208; doi: https://doi.org/10.1101/2022.07.07.22277208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)